GlassScriptPhysician profile
Milli Gupta
NPI 1477831097
$4,371.79
in general payments reported to CMS, 2019-2025
34 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $281 · 2021: $111 · 2022: $248 · 2023: $538 · 2024: $591 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,779 · Gift: $350 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,779.34 |
| Gift | $350.00 |
| Education | $161.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $448.29 | 2019-2024 | |
| Medtronic, INC. | $406.42 | 2023-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Celltrion, INC. | $350.00 | 2025 | Stoboclo |
| Insulet Corporation | $240.58 | 2022-2023 | Omnipod |
| Abbott Laboratories | $233.74 | 2019-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $219.88 | 2019-2025 | Jardiance |
| Beta Bionics, INC. | $209.16 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astrazeneca Pharmaceuticals LP | $205.84 | 2019-2020 | |
| Mannkind Corporation | $199.19 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $193.71 | 2019-2021 | |
| Horizon Therapeutics Plc | $143.60 | 2019-2023 | Tepezza |
| Madrigal Pharmaceuticals | $140.35 | 2025 | Rezdiffra |
| Shire North American Group INC | $139.52 | 2019 | |
| Sequel Med Tech, LLC | $134.32 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $127.24 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $125.00 | 2024 | Watchman Access System |
| Cequr Corporation | $117.20 | 2023 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $95.25 | 2025 | Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $94.45 | 2019 | |
| Abbvie INC. | $80.32 | 2019-2025 | |
| Dexcom, INC. | $73.10 | 2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $63.63 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $60.08 | 2019-2020 | |
| Ibsa Pharma INC. | $45.62 | 2019-2020 | |
| Amarin Pharma, INC. | $35.70 | 2019 | |
| Corcept Therapeutics | $32.11 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $31.40 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $21.73 | 2025 | |
| Becton, Dickinson and Company | $21.05 | 2019 | |
| Ucb, INC. | $19.78 | 2019 | |
| Medtronic Minimed, INC. | $18.50 | 2019 | |
| Gilead Sciences, INC. | $17.30 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.67 | 2019 | |
| Companion Medical, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milli Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.